Tianjin Lisheng Pharmaceutical Co Ltd (002393) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.061x

Based on the latest financial reports, Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a cash flow conversion efficiency ratio of 0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥287.81 Million ≈ $42.12 Million USD) by net assets (CN¥4.69 Billion ≈ $686.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tianjin Lisheng Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Tianjin Lisheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Tianjin Lisheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Tianjin Lisheng Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tianjin Lisheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Lisheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Biotest Aktiengesellschaft XETRA:BIO3	-0.114x
SIS LIMITED NSE:SIS	0.067x
COMPASS PATHW SP.ADR F:5Y6	0.715x
Faeth Therapeutics, Inc. NASDAQ:FTH	-0.056x
Suzhou Longway Electronic Machinery Co. Ltd. A SHE:301202	N/A
Kim Loong Resources Bhd KLSE:5027	0.056x
Chapters Group AG XETRA:CHG	0.040x
JINXIN FERT.GRP HD-00001 F:3NX	N/A

Annual Cash Flow Conversion Efficiency for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Tianjin Lisheng Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.69 Billion ≈ $686.81 Million	CN¥451.85 Million ≈ $66.12 Million	0.096x	+423.55%
2024-12-31	CN¥4.80 Billion ≈ $702.39 Million	CN¥88.26 Million ≈ $12.92 Million	0.018x	-56.96%
2023-12-31	CN¥4.90 Billion ≈ $717.53 Million	CN¥209.51 Million ≈ $30.66 Million	0.043x	-43.92%
2022-12-31	CN¥4.35 Billion ≈ $636.45 Million	CN¥331.38 Million ≈ $48.49 Million	0.076x	+71.15%
2021-12-31	CN¥4.41 Billion ≈ $645.40 Million	CN¥196.34 Million ≈ $28.73 Million	0.045x	+150.77%
2020-12-31	CN¥4.30 Billion ≈ $629.53 Million	CN¥76.37 Million ≈ $11.18 Million	0.018x	-70.78%
2019-12-31	CN¥4.42 Billion ≈ $646.32 Million	CN¥268.33 Million ≈ $39.26 Million	0.061x	+19.96%
2018-12-31	CN¥3.21 Billion ≈ $470.07 Million	CN¥162.69 Million ≈ $23.81 Million	0.051x	-12.99%
2017-12-31	CN¥3.08 Billion ≈ $450.66 Million	CN¥179.25 Million ≈ $26.23 Million	0.058x	+1.09%
2016-12-31	CN¥3.02 Billion ≈ $441.21 Million	CN¥173.60 Million ≈ $25.40 Million	0.058x	-13.70%
2015-12-31	CN¥2.97 Billion ≈ $434.60 Million	CN¥198.13 Million ≈ $28.99 Million	0.067x	+168.73%
2014-12-31	CN¥2.91 Billion ≈ $425.81 Million	CN¥72.24 Million ≈ $10.57 Million	0.025x	-74.94%
2013-12-31	CN¥2.92 Billion ≈ $427.86 Million	CN¥289.62 Million ≈ $42.38 Million	0.099x	+10.09%
2012-12-31	CN¥2.79 Billion ≈ $407.77 Million	CN¥250.72 Million ≈ $36.69 Million	0.090x	+87.07%
2011-12-31	CN¥2.80 Billion ≈ $409.46 Million	CN¥134.58 Million ≈ $19.69 Million	0.048x	-31.68%
2010-12-31	CN¥2.65 Billion ≈ $387.79 Million	CN¥186.55 Million ≈ $27.30 Million	0.070x	-83.10%
2009-12-31	CN¥470.87 Million ≈ $68.90 Million	CN¥196.14 Million ≈ $28.70 Million	0.417x	+56.23%
2008-12-31	CN¥474.77 Million ≈ $69.47 Million	CN¥126.59 Million ≈ $18.52 Million	0.267x	-34.13%
2007-12-31	CN¥432.23 Million ≈ $63.25 Million	CN¥174.94 Million ≈ $25.60 Million	0.405x	--

About Tianjin Lisheng Pharmaceutical Co Ltd

SHE:002393 China Drug Manufacturers - Specialty & Generic

Market Cap

$656.92 Million

CN¥4.49 Billion CNY

Market Cap Rank

#10801 Global

#2919 in China

Share Price

CN¥14.53

Change (1 day)

+0.97%

52-Week Range

CN¥13.78 - CN¥26.70

All Time High

CN¥46.19